Table 3.
Multivariable prognostic factors of poor outcome at 90-day follow-up and mortality
| Factor | Poor outcome |
Mortality |
||||
|---|---|---|---|---|---|---|
| OR | 95% CI | P | OR | 95% CI | P | |
| Active cancer | 11.20 | 4.62–27.14 | <0.001 | 12.17 | 5.45–27.16 | <0.001 |
| Age | 1.02 | 1.00–1.04 | 0.039 | 1.02 | 1.00–1.04 | 0.083 |
| Birth control | 1.17 | 0.52–2.65 | 0.700 | 0.32 | 0.07–1.47 | 0.143 |
| Black race | 2.17 | 1.10–4.27 | 0.025 | 2.62 | 1.20–5.69 | 0.015 |
| Creatinine | 1.97 | 0.72–5.33 | 0.185 | 1.40 | 0.68–2.86 | 0.361 |
| Encephalopathy or coma | 2.71 | 1.39–5.30 | 0.004 | 1.72 | 0.79–3.76 | 0.170 |
| Hemoglobin | 0.86 | 0.77–0.97 | 0.014 | 0.97 | 0.85–1.10 | 0.618 |
| 1+ Hypercoagulable factor | 0.88 | 0.46–1.69 | 0.694 | 0.93 | 0.40–2.14 | 0.857 |
| Cerebral edema on imaging | 0.89 | 0.46–1.72 | 0.726 | 0.90 | 0.41–1.96 | 0.789 |
| Hemorrhage on imaging | 1.62 | 0.85–3.09 | 0.145 | 1.73 | 0.79–3.78 | 0.171 |
| NIHSS | 1.07 | 1.02–1.11 | 0.002 | 1.02 | 0.98–1.07 | 0.338 |
| Prior VTE | 1.64 | 0.71–3.77 | 0.246 | 0.91 | 0.35–2.36 | 0.845 |
| Substance use | 2.34 | 1.16–4.71 | 0.017 | 2.17 | 1.03–4.60 | 0.042 |
OR, odds ratio; CI, confidence interval; NIHSS, National Institutes of Health Stroke Scale; VTE, venous thromboembolism.